Quote

KRAS mutations in pancreatic circulating tumor cells: a pilot study

  • Pancreatic cancer
  • By : Birte Kulemann, Andrew S. Liss, Andrew L. Warshaw, Sindy Seifert, Peter Bronsert, Torben Glatz, Martha B. Pitman, Jens Hoeppner

DOI : 

PMID :

  • 26684803
Download the article

Abstract

Non disponibles.

Keywords

  • Circulating tumor cells; Molecular/genetic status; Pancreatic cancer; Prognosis.

Share on

Navigation

Quel kit correspond à mon application ?

The latest articles.

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer

  • Maxim B Freidin, Andee Tay, Dasha V Freydina, Dimple Chudasama, Andrew G Nicholson, Alexandra Rice, Vladimir Anikin, Eric Lim
  • DOI : 10.1016/j.lungcan.2014.05.017

Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas

  • Hannah R Barber, Claire M Perks, Kathreena M Kurian
  • DOI : 10.3389/fneur.2024.1358531

Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus – Cytomorphological Heterogeneity

  • Clara Braun, Claudia Schmoor, Sylvia Timme-Bronsert, Stefan Fichtner-Feigl, Jens Hoeppner, Birte Kulemann, Jasmina Kuvendjiska
  • DOI : 10.7150/jca.82668
Liquid biopsy for
enhancing patient care
through reliable CTC analysis
Request a quote
Request brochure

Webinar

Circulating Tumor Cell Analysis :
a new workflow combining ScreenCell® Technology
with Stilla Crystal Digital PCR®

Tuesday, April 8, 2025
04:00 PM CET
Wednesday, April 9, 2025
03:00 PM CST
I'm registering now!